SAPTE VINAY 4
4 · Synovics Pharmaceuticals · Filed Jan 29, 2009
Insider Transaction Report
Form 4
Synovics PharmaceuticalsSYVC.OB
SAPTE VINAY
Director10% Owner
Transactions
- Purchase
Series C Convertible Redeemable Preferred Stock
2008-09-25+1,560→ 25,444,700 total(indirect: See Footnote)Exercise: $0.50From: 2008-09-25Exp: 2011-05-09→ Common Stock (1,560,000 underlying) - Purchase
Warrant
2008-09-25+780,000→ 25,444,700 total(indirect: See Footnote)Exercise: $0.75From: 2008-09-25Exp: 2013-09-25→ Common Stock (780,000 underlying)
Footnotes (6)
- [F1]See Exhibit 99.1
- [F2]See Exhibit 99.1
- [F3]See Exhibit 99.1
- [F4]See Exhibit 99.1
- [F5]See Exhibit 99.1
- [F6]See Exhibit 99.1